ACC Asia Conference 2020 Together With SCS 32nd Annual Scientific Meeting

The ACC Asia Conference 2020, held together with the SCA 32nd Annual Scientific Meeting

SAVE THE DATE!
Board Review Course: April 23 – 24, 2020
FIT Jeopardy: April 24, 2020
Leadership Development Program: April 24, 2020
Conference: April 25 – 26, 2020

CONFERENCE OVERVIEW

MOVE INTO AN ERA OF GLOBAL COLLABORATION

United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and the Singapore Cardiac Society (SCS) invite you to join us for an innovative educational experience that will strengthen your everyday practice. The ACC Asia Conference 2020, held together with the SCS 32nd Annual Scientific Meeting, is designed to deliver an engaging forum to critically examine evidence-based strategies as well as contemporary best practices and clinical decision-making to reach our common objective of improving heart health of patients with cardiovascular disease.

Attend this conference and you will:

Challenge the norm: Discuss, share and critique the latest in cardiovascular prevention and care with GLOBAL EXPERTS and return to your practice ready to improve the care of your patients.

Lead the way: LOCAL LEARNING designed to empower you to transform your community through topics such as Top Clinical Trials to Change Your Practice, as well as the latest in acute coronary syndrome, heart failure, valvular disease, arrhythmia and prevention.

Power your mind: Find PRACTICAL SOLUTIONS for everyday problems by using real-world approaches to guideline-driven care. Challenge your knowledge in participant driven sessions such as Rapid Fire ECG and Imaging Interpretation.

Ignite conversation: Network with faculty from leading cardiovascular societies around the world in an intimate setting and CREATE CONNECTIONS with colleagues through shared discussion and bi-directional learning.

PLUS: Enjoy the benefit of ACC International Associate membership for 1 year included with registration.

Strive to be your best and join us in our vision of a world where innovation and knowledge optimize cardiovascular care and outcomes.

TARGET AUDIENCE

This conference is intended for practicing cardiologists, fellows-in-training, nurses, pharmacists and other members of the cardiac care team in the Asia Pacific region.

LEARNING OBJECTIVES

  • Demonstrate appropriate interpretation of cardiovascular guidelines and diagnostic strategies needed in daily practice.
  • Describe the best practices in the treatment of patients with heart failure.
  • Identify prevention strategies for treating cardiovascular disease including CV risk assessment and managing dyslipidemia.
  • Apply the latest evidence to the evaluation, medical management and surgical treatment of patients with valvular heart disease.
  • Evaluate current treatment strategies in the investigation and management of coronary artery disease.
  • Identify best practices for the management of patients with atrial and ventricular arrhythmias.
  • Demonstrate improved ECG interpretation skills.

CONFERENCE OVERALL GOAL

The overall goal of this conference is to examine emerging trends and evidence-based strategies as well as contemporary best practices resulting in guideline-driven, practical cardiovascular prevention and management for patients with cardiovascular disease.

CONFERENCE CHAIRS

Photo

Fred M. Kusumoto, MD, FACC
Director, Heart Rhythm Services
Mayo Clinic
Jacksonville, FL, USA

Photo

Kian Keong Poh, MBBChir, FACC
Associate Professor, Yong Loo Lin School of Medicine, NUS
Senior Consultant Cardiologist, NUHCS, Singapore
Steering Committee, American College of Cardiology AIG
Singapore

PLANNING COMMITTEE

Photo

Toon Wei Lim, MBBS, FRACP, PhD
Senior Consultant, Cardiac Department
National University Heart Centre, Singapore
Vice President, Singapore Cardiac Society
Singapore

Photo

Julian Kenrick Loh, MBBCh BAO (Hons)
Consultant Cardiologist
Director, Coronary Care Unit
National Heart Centre Singapore
Singapore

Photo

Hean Yee Ong, MBBCh BAO, FAMS, FRCP, FACC
President, Singapore Cardiac Society
Singapore

Photo

Edgar Tay, MBBS, FACC
Director, Structural Heart Disease Programme
Senior Consultant Cardiologist
National University Heart Centre Singapore
Governor, ACC Singapore Chapter
Singapore

Photo

Colin Yeo, MBBS, FRCP, DRCPSC
Consultant Cardiologist, Changi General Hospital
Adjunct Assistant Professor, Duke-NUS
Singapore

Photo

Tee Joo Yeo, MBBS, MRCP (UK), MCI (Singapore)
Assistant Professor, Yong Loo Lin School of Medicine, NUS
Consultant Cardiologist and Director, Cardiac Rehabilitation Unit
National University Heart Centre Singapore
Singapore

US FACULTY

Photo

Aaron D. Kugelmass, MD, FACC
Vice President, Baystate Health
Medical Director, Heart and Vascular Program
Chief, Division of Cardiology
Professor of Medicine, University of Massachusetts-Baystate
Springfield, MA, USA

Photo

Matthew W. Martinez, MD, FACC
Atlantic Health - Morristown Medical Center
Gagnon Cardiovascular Institute
Director, Sports Cardiology
Co-Director, Chanin T. Mast Hypertrophic Cardiomyopathy Center
Morristown, NJ, USA

Photo

Paul J. Mather, MD, FACC
Physician Leader, Heart Failure Disease Management, University of Pennsylvania Health System
Director, Faculty Development, Division of Cardiology
Professor of Clinical Medicine, Heart Failure Transplant Program
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA, USA

Photo

Pamela B. Morris, MD, FACC
Professor of Medicine, Cardiology
Director, Seinsheimer Cardiovascular Health Program
Co-Director, Women's Heart Care
Medical University of South Carolina
Charleston, SC, USA

Photo

Athena Poppas, MD, FACC
Vice-President, American College of Cardiology
Chief, Cardiology Division
Director, Lifespan Cardiovascular Institute
Rhode Island, Miriam and Newport Hospitals
Professor of Medicine, Brown University
Providence, RI, USA

Photo

John S. Rumsfeld, MD, PhD, FACC
Chief Innovation Officer, American College of Cardiology
Professor of Medicine, Cardiology
University of Colorado School of Medicine
Denver, CO, USA

Photo

James D. Thomas, MD, FACC
Professor of Medicine, Feinberg School of Medicine, Northwestern University
Director, Center for Heart Valve Disease, Bluhm Cardiovascular Institute, Northwestern University
Director of Academic Affairs, Bluhm Cardiovascular Institute, Northwestern University
Co-Director, Center for Artificial Intelligence in Cardiovascular Disease, Bluhm Cardiovascular Institute, Northwestern University
Past President, American Society of Echocardiography
Lead Scientist for Ultrasound, NASA
Chicago, IL, USA

To register for the ACC Asia Conference 2020 or the ACC Board Review Course, please click here.

Registration Rates

Main Conference + FIT Jeopardy Package + Dinner Symposium Early Bird
(By February 29, 2020)
Regular
(March 1 - April 22, 2020)
Onsite
(April 23 - 26, 2020)
Physician SGD 150.00 SGD 250.00 SGD 350.00
Non-Physician (Allied Health Professionals, Nurses, Fellows-in-Training,* Students, etc.) SGD 50.00 SGD 100.00 SGD 350.00
Singapore Cardiac Society Member Waived Waived Waived
* You must send a letter from your Head of Department to ryoung@acc.org for FIT verification.

ACC Board Review Course Early Bird
(By February 29, 2020)
Regular
(March 1 - April 22, 2020)
Onsite
(April 23 - 26, 2020)
Includes admission into main conference and 30 days of complimentary access to ACCSAP SGD 1,200.00 SGD 1,400.00 SGD 1,600.00

ACC Cardiovascular Overview and Board Review Course

Free registration to the ACC Asia Conference 2020 together with SCS 32nd Annual Scientific Meeting is included, as well as 30-day complimentary access to ACC's ACCSAP, ACC's flagship self-assessment program covering the entire field of adult clinical cardiology.

Perfect your knowledge and receive a comprehensive update of cardiovascular disease with the ACC Cardiovascular Overview and Board Review Course! Join us in April and:

  • Experience a thorough review of the entire field of cardiovascular disease delivered by expert faculty members from the U.S.
  • Stay engaged with a variety of presentation styles: lectures, case-based reviews, interactive case studies, and question challenges
  • Get answers to your individual questions by submitting them to the faculty through an Audience Response System
  • Leave the course feeling updated and confident in your knowledge of cardiovascular medicine.

Over the course of two days, faculty will guide you through intense, interactive study on:

  • Adult Congenital Heart Disease
  • Arrhythmias/EP
  • Coronary Artery Disease
  • Heart Failure
  • Prevention
  • Valvular Heart Disease

Goal
Anchored on the American Board of Internal Medicine (ABIM) Certification Blueprint, the overall goal of this course is to provide healthcare providers with an opportunity to review and update their knowledge and competency in the latest prevention, diagnosis, and treatment of the full spectrum of cardiovascular diseases.

Learning Objectives
Upon completion of this course, learners should be able to —

  • Identify strategies for integrating diagnostic results and patient symptoms to form diagnosis of cardiovascular disease states.
  • Integrate treatment and/or management decisions in the care of patients with cardiovascular disease, including heart failure, valvular disease, and ACS.
  • Identify best-practice guidelines in the care of patients with cardiovascular disease.
  • Recognize indicators for accurate interpretation of ECG, echo, CT scan and other diagnostic methods.
  • Identify gaps in their knowledge base and focus study efforts on filling gap areas.

Target Audience
This course is intended for cardiovascular specialists, physicians and fellows-in-training who are seeking an in-depth review of general cardiology. The secondary target audience is cardiovascular team professionals, including physician assistants and advanced practice nurses.

This program will be held on Thursday and Friday, April 23-24, 2020 in the Grand Hyatt Singapore.

Click here to see the agenda.

Course Directors

Photo

Matthew W. Martinez, MD, FACC
Atlantic Health - Morristown Medical Center
Gagnon Cardiovascular Institute
Director, Sports Cardiology
Co-Director, Chanin T. Mast Hypertrophic Cardiomyopathy Center
Morristown, NJ, USA

Photo

Patrick T. O'Gara, MD, MACC*
Watkins Family Distinguished Chair in Cardiology, BWH
Professor of Medicine, Harvard Medical School
Boston, MA, USA
*will not be onsite at course

Faculty

Philippe Genereux, MD, FACC

Photo

Fred M. Kusumoto, MD, FACC
Director, Heart Rhythm Services
Mayo Clinic
Jacksonville, FL, USA

Photo

Paul J. Mather, MD, FACC
Physician Leader, Heart Failure Disease Management, University of Pennsylvania Health System
Director, Faculty Development, Division of Cardiology
Professor of Clinical Medicine, Heart Failure Transplant Program
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA, USA

Photo

Pamela B. Morris, MD, FACC
Professor of Medicine, Cardiology
Director, Seinsheimer Cardiovascular Health Program
Co-Director, Women's Heart Care
Medical University of South Carolina
Charleston, SC, USA

Photo

Anne Marie Valente, MD, FACC
Section Chief, Boston Adult Congenital Heart Disease Program, Boston Children's Hospital, Brigham and Women's Hospital
Co-Director, Pregnancy and Cardiovascular Disease Program, Brigham and Women's Hospital
Associate Professor of Medicine and Pediatrics, Harvard Medical School
Boston, MA, USA

FIT Jeopardy: The Classic Game Show With a FIT Twist

Join us as ACC international chapter teams and Singapore local teams – each made up of three Fellows in Training (FITs) have the opportunity to test their clinical knowledge during the FIT Jeopardy sessions at the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting!

FIT Jeopardy is a friendly competition that promotes a healthy rivalry between ACC international chapters, fosters FIT engagement within the chapters and provides educational value to the contestants and audience. Participants will be quizzed on a variety of topics ranging from imaging, prevention, and intervention in an unconventional manner. There will be a panel of judges and chairs to moderate the competition.

Three local teams from Singapore and three ACC international chapters teams will compete in preliminary rounds with a final round between the winning local Singapore team and the winning ACC international chapter team. The winning team will compete at the ACC.21 competition in Atlanta in March 2021!

This competition will be held as a free pre-conference opportunity on Friday, April 24, 2020 from 5:00 pm to 9:00 pm in the Grand Hyatt Singapore.

ACC International Leadership Development Program

The American College of Cardiology's Leadership Development Program offers a half-day intensive workshop that addresses various skills and knowledge in cardiovascular leadership. The program design provides you with a broad understanding of leadership styles and skills. This program addresses diverse perspectives on critical leadership challenges while also providing an awareness of concepts and techniques relevant to leading effectively within one's own healthcare institution. The ACC often draws upon those who complete this program for future leadership roles within the College.

While strengthening leadership skills is a primary objective of the training course, the program also leverages having international leaders in the same room as an opportunity to exchange ideas and best practices. Led by ACC President, Dr. Athena Poppas and Conference Co-Chair, Kian Keong Poh, MBBChir, FACC, this interactive discussion allows attendees to provide special insight into their country's healthcare and leadership challenges. The program serves as a platform for emerging leaders in the cardiovascular community to gain a deeper understanding of the varied challenges facing the College's ever-growing international community. By connecting these emerging leaders, the program facilitates the building of professional relationships and creates new opportunities for collaboration that defy geographical distance.

This program will be held as a pre-conference opportunity on Friday, April 24, 2020 from 1:00 pm to 5:00 pm in the Grand Hyatt Singapore.

Thank you for your interest in submitting an abstract to the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting. The abstract submission site is now open and all abstracts must be submitted by 11:59 pm SGT on Tuesday, February 4, 2020.

Please ensure you have read the abstract policies and procedures and submission instructions thoroughly before submitting your abstract.

Please note: Only non-US citizens who are currently residing in Asia are eligible to submit their research.

Follow the directions and be cognizant of the deadline. Given the thorough review process, only submissions recognized as complete will be considered.

Please click on the following link to begin your submission: https://podio.com/webforms/23567553/1694383

For any questions regarding your submission, please contact Robin Young at ryoung@acc.org.

Apply by February 9, 2020!

ACC is hosting an exciting event at the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting — the ACC Innovation Challenge! This ACC version of a competitive pitch competition will include the most innovative startups from around the region, who will pitch their cardiovascular product or service to a live audience and panel of key cardiology opinion leaders from the United States, Singapore, and the Asia Pacific region. Companies completing an application will be selected to present their innovative solutions based on the ingenuity of their product or offering and its ability to solve a problem or meet a critical need in cardiovascular health in ways such as, but not limited to: leveraging digital health platforms, telemedicine ideas, or wearable technologies.

The winner of the Innovation Challenge will receive an opportunity to elevate their vision through international coverage and a cash prize. This event will be a unique opportunity not only for participants but also for the audience to meet innovators who are changing the future of cardiology.

Prize Package:

  • The winner will:
    • Receive a cash prize of $6,000 USD
    • Be featured on the ACC's website and social media outlets
    • Have a brief interview published in the ACC's international newsletter, distributed to over 17,000 practicing cardiologists outside of the United States

Eligibility Criteria:

  • Company must have a product or service relevant to cardiovascular health
  • Must be a registered company and company should have been in existence in its current form for no more than 5 years
  • The innovation must be categorized as digital health/health IT or medical device
  • Each company may only enter one innovation in the challenge

Application Process:

  • Please click the following link to complete your application: https://podio.com/webforms/23814769/1722606
  • Entries that do not comply with the instructions will not be accepted.
  • Please answer each of the application questions in 250-500 words.
  • Application is due no later than February 9, 2020.
  • The application will be scored by a subset of the competition's reviewers using evaluation criteria.
  • Finalists will be notified the week of February 24, 2020 and will be invited to participate in the Innovation Challenge – Asia.

Format of the Innovation Challenge Competition:

  • Each company will have six minutes to present their innovative product/offering and then four minutes of Q&A with the panel of judges.
  • Company representatives will have access to A/V for slides. Companies must present in English.
  • Participating startups to submit pitch PowerPoint presentations decks by April 3, 2020 to innovationdevelopment@acc.org.

Logistics:

  • The Innovation Challenge competition will take place on Saturday, April 25 at the Grand Hyatt Singapore.
  • Selected startups are expected to be in Singapore the day before the competition in order to participate in practice run of challenge.
  • Selected startups are responsible for all costs associated with travel to and lodging in Singapore.
  • Companies selected to the competition will receive free registration for up to 3 company employees, including the Challenge presenter, to the ACC Asia Conference 2020.
  • Each participating company will be scored by the panel of judges on a scale of 1-5 for the attractiveness of their product and its ability to address a critical need in the delivery, treatment, or management of cardiovascular health.

If you have any questions, please reach out to innovationdevelopment@acc.org.